Penetration Testing for Pharmaceutical
Pharmaceutical companies develop and manufacture products that directly impact human health, making them critical infrastructure targets with unique cybersecurity requirements. The industry holds extremely valuable intellectual property including drug formulations, clinical trial data, manufacturing processes, and regulatory submissions worth billions of dollars. Nation-state actors have targeted pharmaceutical companies for COVID-19 vaccine research, and the sector faces ongoing threats from industrial espionage, ransomware, and supply chain attacks.
Penetration testing for pharmaceutical companies must address research and development systems, clinical trial management platforms, manufacturing control systems, quality management systems, and regulatory submission portals. The convergence of IT and OT in pharmaceutical manufacturing creates risks similar to those in other manufacturing sectors, with the added dimension of patient safety and drug quality implications.
Pharmaceutical companies must comply with GxP regulations, HIPAA (for clinical data), GDPR, and FDA cybersecurity guidance for connected medical products. Regular penetration testing helps pharmaceutical companies protect intellectual property, ensure manufacturing integrity, and maintain the trust of regulators and patients.
No providers match your filters.
Pharmaceutical Pen Testing FAQs
What pharmaceutical-specific systems should be tested?+
Priority systems include R&D platforms, clinical trial management, LIMS, manufacturing control systems (SCADA/MES), quality management systems, regulatory submission portals, and supply chain systems.
How do GxP regulations affect pen testing?+
GxP-regulated systems require validated testing approaches, detailed documentation, and careful change control. Pen testing must be planned and documented in accordance with GxP validation requirements.
What IP protection risks should pen testing address?+
Testing should evaluate access controls on research data, security of collaboration platforms, data loss prevention effectiveness, and the security of systems storing drug formulations and manufacturing processes.